SIN-1 Improves Cerebral Blood Flow and Reduces Deviation From Brain Homeostasis During Ischemia and Reperfusion in Rats
Stroke · 2025
DOI: 10.1161/strokeaha.125.052917 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke, 2025. Verfasst von Coline L Lemale und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Stroke Research Berlin (C.L.L., B.B., S.M., J.P.D.), Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and …. Hauptthemen laut MEDLINE: Cerebrovascular Circulation, Homeostasis, Molsidomine, Brain Ischemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Overall, 75% of patients with acute stroke have elevated mean arterial pressure (MAP). In randomized stroke trials, the indirect NO donor glyceryl trinitrate lowered MAP but improved neither regional cerebral blood flow (rCBF) nor functional outcomes. One probable reason is that the microcirculation cannot bioactivate glyceryl trinitrate. In contrast, the direct NO donor 3-morpholinosydnonimine (SIN-1), not requiring bioactivation, should also release NO in small vessels, where it supports eNOS (endothelial NO synthase)–derived NO in maintaining rCBF in the hypotensive portion of Lassen autoregulatory curve. In a meta-analysis, SIN-1 reduced infarct volume in ischemia models, but the effects of SIN-1 on early pathophysiology are unknown. METHODS: Here, we investigated SIN-1 during a 60-minute bilateral common carotid artery occlusion and reperfusion in forty-eight 12- to 14-week-old Wistar-Kyoto rat (WKY) controls and 48 stroke-prone spontaneously hypertensive rats. We calculated the difference between the median values of each variable in the last 5 minutes of bilateral common carotid artery occlusion and baseline and compared them between treatment (SIN-1/control) and strain (stroke-prone spontaneously hypertensive rat/WKY) using 2-way ANOVA. We proceeded in the same way regarding reperfusion. RESULTS: Strain×intervention interaction was only found for MAP during bilateral common carotid artery occlusion. SIN-1 lowered MAP within stroke-prone spontaneously hypertensive rats ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Stroke Research Berlin (C.L.L., B.B., S.M., J.P.D.), Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.
- Department of Experimental Neurology (C.L.L., S.M., J.P.D.), Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.
- Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Germany (L.M.S.-H., P.M.).
- Inserm U1028, CNRS UMR 5292, Lyon Neuroscience Research Center, Team TIGER, Lyon, France (B.B.).
- Université Claude Bernard Lyon1, France (B.B.).
- Department of Neurological Anesthesiology and Intensive Care Medicine, Hospices Civils de Lyon, France (B.B.).
ORCID-Profile: Coline L Lemale, Lina M Serna-Higuita, Baptiste Balança, Sara Simula, Sebastian Major, Ingemar Fredriksson, Jens P Dreier
Zitieren
APA
Lemale, C. L., Serna-Higuita, L. M., Balança, B., Simula, S., Major, S., Martus, P., Fredriksson, I., & Dreier, J. P. (2025). SIN-1 Improves Cerebral Blood Flow and Reduces Deviation From Brain Homeostasis During Ischemia and Reperfusion in Rats. Stroke. https://doi.org/10.1161/strokeaha.125.052917
Vancouver
Lemale CL, Serna-Higuita LM, Balança B, Simula S, Major S, Martus P, et al. SIN-1 Improves Cerebral Blood Flow and Reduces Deviation From Brain Homeostasis During Ischemia and Reperfusion in Rats. Stroke. 2025. doi:10.1161/strokeaha.125.052917
BibTeX
@article{Lemale2025,
author = {Lemale, Coline L and Serna-Higuita, Lina M and Balança, Baptiste and Simula, Sara and Major, Sebastian and Martus, Peter and Fredriksson, Ingemar and Dreier, Jens P},
title = {SIN-1 Improves Cerebral Blood Flow and Reduces Deviation From Brain Homeostasis During Ischemia and Reperfusion in Rats},
journal = {Stroke},
year = {2025},
doi = {10.1161/strokeaha.125.052917}
}
EUVIMED